243 related articles for article (PubMed ID: 22455511)
41. Continuous esomeprazole infusion versus bolus administration and second look endoscopy for the prevention of rebleeding in children with a peptic ulcer.
Belei O; Olariu L; Puiu M; Jinca C; Dehelean C; Marcovici T; Marginean O
Rev Esp Enferm Dig; 2018 Jun; 110(6):352-357. PubMed ID: 29465250
[TBL] [Abstract][Full Text] [Related]
42. Intravenous versus oral omeprazole on patients with high risk bleeding peptic ulcers: A prospective randomized clinical trial protocol.
Zhang J; Diao P; Zhang L
Medicine (Baltimore); 2021 Apr; 100(14):e25136. PubMed ID: 33832076
[TBL] [Abstract][Full Text] [Related]
43. Intermittent vs continuous proton pump inhibitor therapy for high-risk bleeding ulcers: a systematic review and meta-analysis.
Sachar H; Vaidya K; Laine L
JAMA Intern Med; 2014 Nov; 174(11):1755-62. PubMed ID: 25201154
[TBL] [Abstract][Full Text] [Related]
44. Somatostatin adjunctive therapy for non-variceal upper gastrointestinal rebleeding after endoscopic therapy.
Choi CW; Kang DH; Kim HW; Park SB; Park KT; Kim GH; Song GA; Cho M
World J Gastroenterol; 2011 Aug; 17(29):3441-7. PubMed ID: 21876636
[TBL] [Abstract][Full Text] [Related]
45. Intravenous Esomeprazole for Prevention of Peptic Ulcer Rebleeding: A Randomized Trial in Chinese Patients.
Bai Y; Chen DF; Wang RQ; Chen YX; Shi RH; Tian DA; Chen H; Eklund S; Li ZS;
Adv Ther; 2015 Nov; 32(11):1160-76. PubMed ID: 26581750
[TBL] [Abstract][Full Text] [Related]
46. Predicting risk factors for rebleeding, infections, mortality following peptic ulcer bleeding in patients with cirrhosis and the impact of antibiotics prophylaxis at different clinical stages of the disease.
Kuo MT; Yang SC; Lu LS; Hsu CN; Kuo YH; Kuo CH; Liang CM; Kuo CM; Wu CK; Tai WC; Chuah SK
BMC Gastroenterol; 2015 May; 15():61. PubMed ID: 26268474
[TBL] [Abstract][Full Text] [Related]
47. Pantoprazole for the treatment of peptic ulcer bleeding and prevention of rebleeding.
van Rensburg CJ; Cheer S
Clin Med Insights Gastroenterol; 2012; 5():51-60. PubMed ID: 24833934
[TBL] [Abstract][Full Text] [Related]
48. Endoscopic hemostasis followed by preventive transarterial embolization in high-risk patients with bleeding peptic ulcer: 5-year experience.
Kaminskis A; Ivanova P; Kratovska A; Ponomarjova S; Ptašņuka M; Demičevs J; Demičeva R; Boka V; Pupelis G
World J Emerg Surg; 2019; 14():45. PubMed ID: 31516544
[TBL] [Abstract][Full Text] [Related]
49. Predictive factors of rebleeding and mortality following endoscopic hemostasis in bleeding peptic ulcers.
Bratanic A; Puljiz Z; Ljubicicz N; Caric T; Jelicic I; Puljiz M; Perko Z
Hepatogastroenterology; 2013; 60(121):112-7. PubMed ID: 22709912
[TBL] [Abstract][Full Text] [Related]
50. Diagnosis and management of nonvariceal upper gastrointestinal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) Guideline.
Gralnek IM; Dumonceau JM; Kuipers EJ; Lanas A; Sanders DS; Kurien M; Rotondano G; Hucl T; Dinis-Ribeiro M; Marmo R; Racz I; Arezzo A; Hoffmann RT; Lesur G; de Franchis R; Aabakken L; Veitch A; Radaelli F; Salgueiro P; Cardoso R; Maia L; Zullo A; Cipolletta L; Hassan C
Endoscopy; 2015 Oct; 47(10):a1-46. PubMed ID: 26417980
[TBL] [Abstract][Full Text] [Related]
51. Oral proton pump inhibitors are as effective as endoscopic treatment for bleeding peptic ulcer: a prospective, randomized, controlled trial.
Kim JI; Cheung DY; Cho SH; Park SH; Han JY; Kim JK; Han SW; Choi KY; Chung IS
Dig Dis Sci; 2007 Dec; 52(12):3371-6. PubMed ID: 17514424
[TBL] [Abstract][Full Text] [Related]
52. [Prevalence of rebleeding from peptic ulcer in patients treated with proton pump inhibitors].
Garrido A; Iborra MI; Saperas E; de Sousa M;
Med Clin (Barc); 2010 May; 134(13):577-82. PubMed ID: 20189198
[TBL] [Abstract][Full Text] [Related]
53. Current managements and outcomes of peptic and artificial ulcer bleeding in Japan.
Fujishiro M; Abe N; Endo M; Kawahara Y; Shimoda R; Nagata S; Homma K; Morita Y; Uedo N
Dig Endosc; 2010 Jul; 22 Suppl 1():S9-14. PubMed ID: 20590780
[TBL] [Abstract][Full Text] [Related]
54. WITHDRAWN: Proton pump inhibitor treatment for acute peptic ulcer bleeding.
Leontiadis GI; Sharma VK; Howden CW
Cochrane Database Syst Rev; 2010 May; 2010(5):CD002094. PubMed ID: 20464720
[TBL] [Abstract][Full Text] [Related]
55. Standard and double-dose intravenous proton pump inhibitor injections for prevention of bleeding after endoscopic resection.
Jung SW; Kim SY; Choe JW; Hyun JJ; Jung YK; Koo JS; Yim HJ; Lee SW
J Gastroenterol Hepatol; 2017 Apr; 32(4):778-781. PubMed ID: 27637734
[TBL] [Abstract][Full Text] [Related]
56. Peptic ulcer bleeding patients with Rockall scores ≥6 are at risk of long-term ulcer rebleeding: A 3.5-year prospective longitudinal study.
Yang EH; Cheng HC; Wu CT; Chen WY; Lin MY; Sheu BS
J Gastroenterol Hepatol; 2018 Jan; 33(1):156-163. PubMed ID: 28497645
[TBL] [Abstract][Full Text] [Related]
57. Proton pump inhibitor treatment for acute peptic ulcer bleeding.
Leontiadis GI; Sharma VK; Howden CW
Cochrane Database Syst Rev; 2006 Jan; (1):CD002094. PubMed ID: 16437441
[TBL] [Abstract][Full Text] [Related]
58. High- versus low-dose proton pump inhibitors after endoscopic hemostasis in patients with peptic ulcer bleeding: a multicentre, randomized study.
Andriulli A; Loperfido S; Focareta R; Leo P; Fornari F; Garripoli A; Tonti P; Peyre S; Spadaccini A; Marmo R; Merla A; Caroli A; Forte GB; Belmonte A; Aragona G; Imperiali G; Forte F; Monica F; Caruso N; Perri F
Am J Gastroenterol; 2008 Dec; 103(12):3011-8. PubMed ID: 19086953
[TBL] [Abstract][Full Text] [Related]
59. Intravenous esomeprazole: a pharmacoeconomic profile of its use in the prevention of recurrent peptic ulcer bleeding.
Keating GM
Pharmacoeconomics; 2011 Jun; 29(6):535-43. PubMed ID: 21568358
[TBL] [Abstract][Full Text] [Related]
60. Seven-day intravenous low-dose omeprazole infusion reduces peptic ulcer rebleeding for patients with comorbidities.
Cheng HC; Chang WL; Yeh YC; Chen WY; Tsai YC; Sheu BS
Gastrointest Endosc; 2009 Sep; 70(3):433-9. PubMed ID: 19500787
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
